Patents Assigned to Alimunne, L.L.C.
  • Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
    Patent number: 7160987
    Abstract: A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens, including the CD45RB epitope.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: January 9, 2007
    Assignee: Alimunne, L.L.C.
    Inventors: Andrew I. Lazarovits, Sibrand Poppema